Vice Secretary-General Qu Fenghong of the National Committee of the Chinese People's Political Consultative Conference, along with Director Jiao Hong and her delegation from the National Medical Products Administration, visited our company for an inspection.-BIOTECH PHARMACEUTICAL CO., LTD_EGF Vaccine

Home
About Us
About Us

BPL is a high-tech China-Cuba joint venture among first group engaged in the development, production and sales of monoclonal antibodies in China.
S&T
S&T

International-standard humanized monoclonal antibody preparation processes and large-scale, continuous mammalian cell culture technology.
- Research Areas
- Technology Platforms
Research and Development
Research and Development

China has developed nivolumab, a humanized monoclonal antibody drug (trade name: TaiXinSheng), for the treatment of malignant tumors.
Blog
Blog

Integrating industry-related media coverage as well as the company’s various activities and updates.
- Company News
- Media Reports
Join Us
Join Us

Boasting a postdoctoral research workstation and diverse career opportunities, we sincerely invite talented individuals from all fields to join Baite.
- Post-Doctoral Center
Contact Us
Contact Us

ThaiXinLife Consultation Hotline: +86 4006592330
Company Main Line: +86-10-51571020
- Contact Us

Vice Secretary-General Qu Fenghong of the National Committee of the Chinese People's Political Consultative Conference, along with Director Jiao Hong and her delegation from the National Medical Products Administration, visited our company for an inspection.

Category:

Company News

Author:

Source:

Release date:

2020-11-03

2020 Year 10 Month 28 On the same day, Qu Fenghong, Vice Secretary-General of the National Committee of the Chinese People's Political Consultative Conference and Executive Vice Chairman & Secretary-General of the Central Committee of the China Association for Promoting Democracy, along with Jiao Hong, Vice Chairman of the Central Committee of the China Association for Promoting Democracy and Director of the National Medical Products Administration, visited our company for an inspection. Chairman Bai Xianhong shared Biotech Pharma’s development journey, key achievements, and its strategic roadmap for the future.